Plague Scare Makes NVAX Climb

Welcome to LazyListen. This is The Daily Rip for today. Stocks pushed higher Monday, led by a record-setting rally in Nvidia that helped the Nasdaq hit fresh highs.

It’s a quiet stretch between earnings seasons, with the main market catalysts this week being Wednesday’s Federal Reserve minutes and Delta’s earnings on Thursday. Outside of that, investors are mostly watching bond yields and oil prices for direction. The major indexes all closed in positive territory: the S&P 500 gained about seven-tenths of a percent, the Nasdaq climbed one percent, the Dow added two-tenths, and the Russell 2000 small-cap index rose six-tenths.

Sector-wise, materials led the way, up one and a half percent, while real estate lagged slightly, down less than half a percent. The 10-year Treasury yield ticked up to just over five point three percent, while crude oil prices eased about two percent to around eighty-nine dollars a barrel, extending Friday’s rally on expectations that the Fed may pause rate hikes. One of the day’s most notable moves came from Novavax, the vaccine maker, which surged nearly twenty-six percent.

This jump was sparked by speculation around a plague outbreak in Russia, following reports of a lab incident in Siberia where a researcher fell ill and later died from pneumonia. While there’s no confirmed outbreak or connection to Novavax’s products—they don’t make plague vaccines—the headlines triggered a classic market reflex: vaccine stocks rallying on outbreak fears. Trading volume in Novavax was more than five times its usual pace, and the stock hit a fresh 52-week high near thirteen dollars and thirty cents.

It’s worth noting the company had some earlier news about expanded work with a partner on pipeline projects, but that was three weeks ago and didn’t drive today’s move. So, this is mostly headline-driven momentum, not fundamental news. In chip stocks, Cerebras Systems rebounded sharply, gaining over nine percent after a rough week.

The company, known for making some of the largest computer chips designed to accelerate artificial intelligence workloads, had fallen after a report suggested OpenAI would rely on Nvidia GPUs rather than Cerebras chips for its upcoming GPT model. Adding to the pressure, a large block of insider shares became available. But then OpenAI CEO Sam Altman posted publicly that Cerebras remains a close partner, pushing back against speculation of a cooling relationship.

Cerebras shares closed around one hundred eighty-two dollars, still down over forty percent for the year. The company recently declined a potential acquisition offer from Nvidia, choosing to stay independent while securing a major compute deal with OpenAI. Investors will be watching for signs of margin stabilization to lift sentiment further.

In a major deal in industrial software, Schneider Electric agreed to acquire PTC, a Boston-based company specializing in design and product lifecycle software used by manufacturers. The all-cash offer values PTC at twenty-two point six billion dollars, or two hundred and five dollars per share, a premium of over forty percent to Friday’s close. PTC shares surged more than thirty-three percent on the news, marking their biggest daily jump ever.

I. data specialist Cognite, so this deal rounds out its software portfolio, covering the design phase before manufacturing operations begin. The combined business would serve over fifty thousand customers and generate nearly a quarter of Schneider’s revenue, with expected cost savings and revenue synergies in the hundreds of millions of euros over the next few years.

Despite the jump, PTC shares still closed below the offer price, reflecting investor caution about regulatory approval and deal timing. Looking at other movers, the biotech sector had mixed action. Capricor fell almost thirteen percent after data showed its drug slowed upper-limb decline in a trial extension, but lingering FDA concerns kept the stock under pressure.

Meanwhile, Moderna climbed nearly seven percent ahead of its return to the Nasdaq-100 index next week, which should bring fresh buying from index funds after a strong run this year. H. Robinson dropped nearly eleven percent following its announcement to acquire freight broker RXO for nearly six billion dollars, marking its largest deal to expand its trucking and last-mile delivery network.

Applied Digital, a digital infrastructure company, slipped a couple of percent despite completing another seventy-five megawatts of capacity at its Polaris Forge site, bringing total live capacity to two hundred fifty megawatts. Investors are likely cautious ahead of the company’s fiscal first-quarter report this Wednesday. Looking ahead to Tuesday, the economic calendar features trade balance data early in the morning, followed by the GDPNow estimate from the Atlanta Fed.

Later in the day, Dallas Fed President Lorie Logan is scheduled to speak. On the earnings front, Constellation Brands and Penguin Solutions report after the market close. So, the market is holding steady with leadership from tech and industrial software, while headline-driven moves in vaccine stocks remind us how quickly sentiment can shift on unexpected news.

With limited big-picture catalysts this week, traders will be watching closely for clues from the Fed minutes and key earnings to set the tone for the rest of the quarter. Thanks for listening. Catch you next time on LazyListen.